11 November, Thursday, 12:30 – 14:00
Hear about innovative programs, projects, and good practices from various organizations thru these lightning talks.
Accreditation in 2030
Presented by: Dr. Carsten Engel
The presentation will give attendees an overview of current trends that impact on accreditation and of visions for accreditation 2030.
The new Standards for Health Promoting Hospitals and Health Services: Optimizing health gain and building sustainable societies
Presented by: Dr. Oliver Groene
The new 2020 Standards for Health Promoting Hospitals and Health Services reflect various novel areas of policy, practice, and evidence in order to support a broader implementation of the HPH vision. They build upon years of work within the HPH Network, as well as the developmental work for new standards in areas such as health literate organizations, standards for specific target groups such as the elderly, and thematic areas such as children and adolescent rights, environmental sustainability, and the societal impact of health care.
Pandemic drives health care provider and industry partnership
Presented by: Daniel Piro
Vizient is a member-owned health care performance improvement company with more than 50% of acute care hospitals and 95% of academic medical centers in the US participating. Vizient members network with colleagues to improve cost, quality and market performance. They purchase approximately $100B of goods and services through Vizient contracts annually. Through the pandemic, Vizient was in a unique position to help connect the leaders that are responsible for utilization of supplies, clinical outcomes and the supply sourcing to partner and positively impact COVID care delivery and response.
This presentation will share how Vizient worked with its member hospital executives and clinical leaders, medical suppliers and government agencies during the pandemic and what they learned, what has changed and what priorities they see for the future.
Establishment of the clean clinic for women and child health services, in Dubai Health Authority during the COVID-19 pandemic
Presented by: Dr. Mai Ghubash
Due to the COVID-19 pandemic, the show up rate for child health vaccination and pre-natal care dropped significantly due to the fear of the ongoing pandemic. April 2020 the decision was to establish the concept of the “clean clinic” at the Dubai Health Authority.
The clean clinic is defined as a clinic free of suspected or confirmed cases of COVID-19 or any symptoms of infectious disease. The target of this clinic was mainly providing services for children and pregnant women.
The presenter will discuss the establishment of the clinic and its impact on the services.
Surgical operating safety during COVID: Multipurpose operating room
Presented by: Carmen Carmona Gallardo
The Multipurpose Operating Room for COVID patients and NON-COVID patients is a response to the problems that have been triggered by the COVID pandemic crisis in the surgical field.
With the solution that has been implemented, it has been possible to give an effective response to the problems that have arisen in the surgical field, guaranteeing the environmental quality conditions of the operating room and consequently patient safety and optimizing the occupation of the operating room for both types of patient, COVID and non-COVID.
Centralisation policy for complex cancer treatments in Catalonia (Spain): Easy to audit and edit?
Presented by: Prof. Joan Prades
This presentation will cover the description of components of the centralisation policy in Catalonia for highly-complex cancer diseases, and a brief comparative perspective with respect to other reforms. An analysis of the indirect and unintended effects of the centralisation policy into the wider healthcare system will also be discussed together with challenges of the reform in terms of vertical and horizontal integration. COVID-19 issues will be also indirectly dealt with.
Quality-of-life measurement as a tool to improve hospital practices: The Feel’HAD study
Presented by: Dr. Marc Poterre
As hospital operators, we tend to have a standardized approach to care. However, quality of life and other patient preference studies show that there is a need to tailor the procedures more precisely to different patient groups. The Feel-HAD study brings additional data supporting this concept.
Beyond measuring: Cultural change towards measuring patient outcomes and continuous improvement of the Stroke care pathway
Presented by: Dr. Marta Rubiera
Hospital Universitari Vall d’Hebron is implementing a comprehensive organizational transformation under the philosophy of Value Based Healthcare for stroke patients. For this, an original methodology was developed to carry out a transformation towards process management, measurement of health outcomes and calculation of costs among other aspects. One year and a half after implementation, the patients’ compliance of the questionnaires of the PROMs at 7 days was 75% and at 90 days it was 65%. Poor outcomes were detected in a high proportion of patients. Measures designed to increase compliance and improve outcomes are being implemented now.
Payment-by-results Schemes for new cancer drugs: 10 years experience from a comprehensive cancer center, Catalan Institute of Oncology
Presented by: Dr. Ana Clopés
Therapeutic innovation is often associated with uncertainties. When there is uncertainty, incentive-based schemes as payment-by-results schemes (PbR) could be alternatives to traditional fixed payment schemes.
The main objective is to present the results of the application of this PbR in a Comprehensive cancer center during a period of 10 years. During this period, ICO has signed 17 PbR with 10 pharmaceutical industries. PbR has allowed ICO to enhance their results-oriented policy participated by health professionals, to determine therapeutic value, strengthening the changing relationship with pharmaceutical industry aimed at co-responsibility in results.
Breast Cancer Patients (BCPS): First results of shared follow-up between Primary Care and hospital (ACMA)
Presented by: Mireia Martinez
A collaborative program for follow-up with BCPs: after initial hospital treatment, BCPs will have alternate appointments between the hospital and Primary Care Centers (PCCs) and receive the advantages of health promotion in Primary Care (PC) and breast cancer knowledge in the Hospital.
Central Lisbon University Hospital Centre Ambulance Transportation management quality improvement program
Presented by: Dr. Leandro Luís
The presenter will share the experience of transformation that were implemented in the Transportation Management Unit from the Central Lisbon Hospital Centre, using a quality driven approach. The Ambulance Transportation Unit was working for many years without a strategy for improving quality and client approach. They identified some of the major problems and started a solution-oriented approach using a balanced-scorecard that allowed to define responsibilities, and put in order a continuous improvement approach. This strategy is continuous and always ongoing, but for now they got better data, better response time and better employee satisfaction. You will see the results from their strategy.
How to optimize frail patient care in a Hemodialysis unit: New challenges
Presented by: Dr. Marta Arias Guillén
Frailty is a strong predictor for the appearance of adverse events such as falls, fractures, cognitive decline, decreased quality of life and mortality, which represents a new scenario related with CKD patients care.
In view of the results obtained evaluating the fragility of the presenter’s hemodialysis patients (25% were classified as fragile and 45% as prefragile) a structural reform of the management of the dialysis unit was considered necessary to compensate for the gap between their patient profile and the care activity offered, in order to provide more individualized care according to the needs detected.
Cost-effectiveness of test biomarkers pre-hospital guided tPA in patients with stroke: Markov model
Presented by: Prof. Antoni Serrano Blanco
Thrombolysis with recombinant tissue plasminogen activator for ischemic stroke is an effective treatment, but it has a reduced therapeutic window. Using a biomarker blood-test in the ambulance to differentiate the type of stroke and treat the patient immediately, could be a great challenge for the management of this disease. The efficiency of this biomarker test is still unknown. The authors built a decision model based in literature review, clinical expert’s opinion and an ongoing clinical trial to assess the efficiency of the blood test-based pre-hospital treatment t-PA biomarker and guide recommendations for its use in Spain in stroke patients.